Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 13
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Ambroxol Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021 2 0
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 5 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0